ArticleCancer research communications2023

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia.

Kazuharu Kamachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.